From the impact of Obamacare to cutting-edge research, biotech buyouts to Big Pharma court battles, The Motley Fool's health-care team sits down each week to discuss the most fascinating developments across the health-care industry, and their implications for long-term investors. In this week's edition, the team talks about Novartis' patent dispute, stocks that have both popped and plummeted, and companies our analysts will be watching in the coming days.
In the following segment, health-care analyst Max Macaluso discusses President Obama's recent announcement of the $100 million "BRAIN Initiative" and how this project can help drugmakers, including Eli Lilly (LLY 0.69%) and Merck, that are developing new treatments for Alzheimer's disease.
The relevant video segment can be found between 4:02 and 5:27.
